Н. С. Бесова
Russian Cancer Research Center NN Blokhin · 111 works · 70 citations · h-index 3
Top works
- ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE
- Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal
- 50P Prognostic value of disseminated tumor cells (DTC) identification in bone marrow from patients with advanced gastric or esophagogastric junction (EGJ) adenocarcinoma (interim results)
- Russian consensus on prevention, diagnosis and treatment of gastric cancer
- Практические рекомендации по лекарственному лечению рака желудка
- Results of the clinical trial of transdermal therapeutic system-fentanyl in strong opioid pre-treated adult patients with cancer-related pain.
- The results of treatment for resectable gastric cancer with microsatellite instability
- Ramucirumab in the treatment of refractory metastatic gastric cancer: Results from the RamSelGa trial
- Abstract 3481: Pharmacokinetics of alofanib and biomarker analysis in patients with advanced gastric cancer: A phase 1b study
- THE USE OF PACLITAXEL IN CHEMORADIOTHERAPY OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL: A PILOT STUDY
- Efficacy of immunotherapy in advanced gastric cancer: preliminary results of a multicenter observational study
- Практические рекомендации по лекарственному лечению рака пищевода и пищеводно-желудочного перехода
- Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial
- Real-world treatment patterns among patients with advanced gastric cancer in Russia: a chart review study
- 450P Neoadjuvant chemo-immunotherapy in mismatch repair deficient (dMMR)/microsatellite instability (MSI) gastric carcinoma (GC): A multicenter retrospective study
- REAL-LIFE CLINICAL UTILITY OF RAMUCIRUMAB FOR THE TREATMENT OF PATIENTS WITH DISSEMINATED GASTRIC ADENOCARCINOMA: PRELIMINARY REVIEW OF THE EXPERIENCE OF BLOKHIN RUSSIAN CANCER RESEARCH CENTRE
- Phase II trial of oxaliplatin (OXA) and topotecan (TOP) as a first line treatment for the patients (pts) with advanced ovarian cancer (AOC): Preliminary results of a pilot study
- Russian consensus on prevention, diagnosis and treatment of gastric cancer. Systemic therapy issues
- Immune checkpoint inhibitors in patients with advanced gastric cancer: a multi-institutional retrospective real-world study
- Perioperative chemotherapy with FLOT regimen in patients with resectable gastric or gastroesophageal junction adenocarcinoma (SIEWERT type I–III). Experience of the N. N. Blokhin russian cancer research center